Search Medical Condition
Please enter condition
Please choose location from dropdown

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (559) clinical trials

What is Alpha-1 Antitrypsin Deficiency? Alpha-1 Antitrypsin Deficiency is a genetic (inherited) condition that may result in serious lung disease in adults and/or liver disease at any age. Alpha-1 Antitrypsin Deficiency occurs when there is a lack of a protein in the blood called alpha-1 antitrypsin, or AAT. AAT is ...

Phase N/A

Chronic Obstructive Pulmonary Disease (COPD) includes chronic bronchitis and emphysema. If you have COPD you may be interested in volunteering for our COPD clinical research study.

Phase N/A

Announcing a new research study of nutritional supplements Specifically, the study will examine whether certain supplements can reduce readmission rates in adults >65 years of age who are hospitalized for the following diagnoses: Heart attack Heart failure COPD Pneumonia

Phase N/A

The overall objective of this study is to assess the efficacy and safety of treatment with PT003 (GFF MDI), PT005 (FF MDI), PT001 (GP MDI), and open-label tiotropium bromide inhalation powder compared with each other and Placebo MDI over 24 weeks in subjects with moderate to very severe COPD.

Phase

This study will be a double-blind, randomized, placebo controlled, parallel-group study to evaluate the effect of Aclidinium bromide on the cardiovascular safety and COPD exacerbations in patients with moderate to very severe COPD, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (GOLD, 2011). The objectives ...

Phase

If you or a loved one has Chronic Obstructive Pulmonary Disease (COPD), you may be interested in this clinical research study. This study is testing the benefits of an investigational drug in reducing lung and heart complications in people with COPD.

Phase N/A

The purpose of this study is to evaluate the safety, tolerability and efficacy of inhaled aclidinium bromide at two dose levels in patients with moderate to severe, stable chronic obstructive pulmonary disease. The study will be 56 weeks in duration; a 2-week rin-in period, a 52-week treatment period and a ...

Phase

Are you experiencing Chronic Obstructive Pulmonary Disease (COPD)? Is your COPD moderate to severe you may be interested in learning more about a clinical research study that we are conducting.

Phase

Are you a current or former smoker? Do you have trouble breathing or a persistent cough? If so, you may have a disease called Chronic Obstructive Pulmonary Disease or COPD. We are looking for people who are between 40 and 80 years old with COPD to participate in a clinical ...

Phase N/A

A 24 week randomized, double-blind, chronic dosing, placebo controlled study group to assess the effect and safety of PT003, PT005, and PT001 in subjects with moderate to severe COPD.

Phase N/A